Literature DB >> 9196415

Factors affecting the therapeutic choice in patients with multivessel coronary artery disease. The Studio Lombardo Angiografia Multivasali (SLAM) Study Group.

S De Servi1, S Galli, M Onofri, E Boschetti, R Oberti, L Niccoli, A M De Biase, G Rovelli, M Carini, F Regalia, P Valentini, A Bartorelli.   

Abstract

OBJECTIVE: To assess how clinical and angiographic findings are related to the decision to carry out coronary angioplasty (PTCA) or coronary bypass grafting in patients with multivessel coronary artery disease.
DESIGN: Prospective survey carried out in 14 centres in the Lombardia region of Italy. PATIENTS: 1468 consecutive patients under going coronary arteriography for known or suspected ischaemic heart disease between May and October 1994, who were found to have multivessel coronary artery disease. MAIN OUTCOME MEASURES: Multivariate analysis was undertaken using stepwise logistic regression to identify the clinical and angiographic variables correlated with revascularisation (v medical treatment) in all of patients, and with surgery (v angioplasty) in the subset of revascularised patients.
RESULTS: In all patients the clinical decision after coronary arteriography was made by physicians of each participating centre on the basis of their experience and clinical judgment: 53% of patients had bypass surgery, 28% had PTCA, and 19% continued medical treatment. The choice of a revascularisation procedure was directly related to a clinical diagnosis of unstable angina (P < < 0.001), the presence of left anterior descending artery disease (P < < 0.001), and to an ejection fraction > or = 40% (P < < 0.001), and inversely related to history of previous coronary bypass surgery (P < < 0.001). In revascularised patients, bypass surgery was the preferred treatment in patients with left anterior descending artery disease (P < < 0.001), three-vessel disease (P < < 0.001), and in those with at least one occluded vessel (P = 0.008). The choice of PTCA was significantly related to history of previous PTCA (P < < 0.001) or coronary bypass surgery (P < < 0.001), to a clinical diagnosis of non-Q wave myocardial infarction (P = 0.002), and to the possibility of implanting an intracoronary stent (P = 0.01).
CONCLUSIONS: Bypass surgery is still the most widely used treatment for patients with multivessel coronary artery disease. This analysis provides a basis for comparison with future developments in the treatment of such patients. Further advancements in PTCA technology are needed to tilt the balance in favour of this less invasive procedure.

Entities:  

Mesh:

Year:  1997        PMID: 9196415      PMCID: PMC484767          DOI: 10.1136/hrt.77.5.443

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

Review 1.  Coronary angioplasty for unstable angina.

Authors:  P J de Feyter
Journal:  Am Heart J       Date:  1989-10       Impact factor: 4.749

2.  Validation of a method for estimating success and complication rates of multivessel angioplasty. A key to the future.

Authors:  T J Ryan
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

3.  Coronary artery bypass surgery vs coronary angioplasty: from antithesis to synthesis.

Authors:  A P Dimas; B Healy
Journal:  Eur Heart J       Date:  1989-12       Impact factor: 29.983

4.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man.

Authors:  H Sandler; H T Dodge
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

5.  Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

Authors:  S G Ellis; M G Vandormael; M J Cowley; G DiSciascio; U Deligonul; E J Topol; T M Bulle
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

6.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

7.  Twelve-year follow-up of survival in the randomized European Coronary Surgery Study.

Authors:  E Varnauskas
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

8.  Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease.

Authors:  W S Weintraub; E L Jones; S B King; J Craver; J S Douglas; R Guyton; H Liberman; D Morris
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

9.  Emergency stenting for acute occlusion after coronary balloon angioplasty.

Authors:  U Sigwart; P Urban; S Golf; U Kaufmann; C Imbert; A Fischer; L Kappenberger
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

10.  Effect of the increasing use of coronary angioplasty on outcome at one year in patients with unstable angina.

Authors:  S De Servi; P Valentini; L Angoli; E Bramucci; P Barberis; G Mariani; G Specchia
Journal:  Br Heart J       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.